From immune hub decoupling to cascade recoupling: rewiring the tumor microenvironment to convert cold tumors to hot tumors

Immune checkpoint inhibitors have transformed cancer treatment, but responses remain limited in many advanced solid tumors, especially immunologically “cold” tumors. Resistance often reflects defects at several stages of the antitumor immune response rather than failure of a single pathway. Tumors can impair antigen presentation, restrict immune-cell trafficking, maintain suppressive cell populations, and impose metabolic constraints on effector cells. These defects can disconnect otherwise coordinated immune processes, a state we describe as immune hub decoupling . This review examines how cellular, stromal, vascular, and metabolic mechanisms contribute to such decoupling and discusses strategies to restore their functional connections. Key approaches include improving antigen presentation, normalizing tumor vasculature and stroma, targeting suppressive immune cells, and relieving metabolic restrictions on effector lymphocytes. Treatment timing and local delivery provide additional means to coordinate these interventions. We further discuss how spatial multi-omics, responsive delivery systems, and synthetic immunology may help identify and target disrupted immune connections. Together, these strategies provide a framework for restoring antitumor immunity in immunologically cold tumors.